SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.16

773.38

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

Advik Capital reports consolidated net profit of Rs 0.59 crore in the September 2025 quarter

Oct 16,2025

Net profit of Advik Capital reported to Rs 0.59 crore in the quarter ended September 2025 as against net loss of Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 94.46% to Rs 5.67 crore in the quarter ended September 2025 as against Rs 102.37 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.67	102.37	-94
OPM %	73.19	2.35	-
PBDT	0.60	0.14	329
PBT	0.10	-0.02	LP
NP	0.59	-0.19	LP

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)